Cargando…

Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development

Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Okito, Yoshida, Makiko, Koma, Yu‐ichiro, Yanai, Tomoko, Hasegawa, Daiichiro, Kosaka, Yoshiyuki, Nishimura, Noriyuki, Yokozaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095779/
https://www.ncbi.nlm.nih.gov/pubmed/27425378
http://dx.doi.org/10.1002/path.4769
_version_ 1782465346004844544
author Hashimoto, Okito
Yoshida, Makiko
Koma, Yu‐ichiro
Yanai, Tomoko
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Nishimura, Noriyuki
Yokozaki, Hiroshi
author_facet Hashimoto, Okito
Yoshida, Makiko
Koma, Yu‐ichiro
Yanai, Tomoko
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Nishimura, Noriyuki
Yokozaki, Hiroshi
author_sort Hashimoto, Okito
collection PubMed
description Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages and fibroblasts) are unclear. Here, we examined 41 cases of neuroblastoma using immunohistochemistry for the tumour‐associated macrophage (TAM) markers CD68, CD163, and CD204, and a cancer‐associated fibroblast (CAF) marker, alpha smooth muscle actin (αSMA). Each case was assigned to low/high groups on the basis of the number of TAMs or three groups on the basis of the αSMA‐staining area for CAFs. Both the number of TAMs and the area of CAFs were significantly correlated with clinical stage, MYCN amplification, bone marrow metastasis, histological classification, histological type, and risk classification. Furthermore, TAM settled in the vicinity of the CAF area, suggesting their close interaction within the tumour microenvironment. We next determined the effects of conditioned medium of a neuroblastoma cell line (NBCM) on bone marrow‐derived mesenchymal stem cells (BM‐MSCs) and peripheral blood mononuclear cell (PBMC)‐derived macrophages in vitro. The TAM markers CD163 and CD204 were significantly up‐regulated in PBMC‐derived macrophages treated with NBCM. The expression of αSMA by BM‐MSCs was increased in NBCM‐treated cells. Co‐culturing with CAF‐like BM‐MSCs did not enhance the invasive ability but supported the proliferation of tumour cells, whereas tumour cells co‐cultured with TAM‐like macrophages had the opposite effect. Intriguingly, TAM‐like macrophages enhanced not only the invasive abilities of tumour cells and BM‐MSCs but also the proliferation of BM‐MSCs. CXCL2 secreted from TAM‐like macrophages plays an important role in tumour invasiveness. Taken together, these results indicate that PBMC‐derived macrophages and BM‐MSCs are recruited to a tumour site and activated into TAMs and CAFs, respectively, followed by the formation of favourable environments for neuroblastoma progression. © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
format Online
Article
Text
id pubmed-5095779
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-50957792016-11-09 Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development Hashimoto, Okito Yoshida, Makiko Koma, Yu‐ichiro Yanai, Tomoko Hasegawa, Daiichiro Kosaka, Yoshiyuki Nishimura, Noriyuki Yokozaki, Hiroshi J Pathol Original Papers Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages and fibroblasts) are unclear. Here, we examined 41 cases of neuroblastoma using immunohistochemistry for the tumour‐associated macrophage (TAM) markers CD68, CD163, and CD204, and a cancer‐associated fibroblast (CAF) marker, alpha smooth muscle actin (αSMA). Each case was assigned to low/high groups on the basis of the number of TAMs or three groups on the basis of the αSMA‐staining area for CAFs. Both the number of TAMs and the area of CAFs were significantly correlated with clinical stage, MYCN amplification, bone marrow metastasis, histological classification, histological type, and risk classification. Furthermore, TAM settled in the vicinity of the CAF area, suggesting their close interaction within the tumour microenvironment. We next determined the effects of conditioned medium of a neuroblastoma cell line (NBCM) on bone marrow‐derived mesenchymal stem cells (BM‐MSCs) and peripheral blood mononuclear cell (PBMC)‐derived macrophages in vitro. The TAM markers CD163 and CD204 were significantly up‐regulated in PBMC‐derived macrophages treated with NBCM. The expression of αSMA by BM‐MSCs was increased in NBCM‐treated cells. Co‐culturing with CAF‐like BM‐MSCs did not enhance the invasive ability but supported the proliferation of tumour cells, whereas tumour cells co‐cultured with TAM‐like macrophages had the opposite effect. Intriguingly, TAM‐like macrophages enhanced not only the invasive abilities of tumour cells and BM‐MSCs but also the proliferation of BM‐MSCs. CXCL2 secreted from TAM‐like macrophages plays an important role in tumour invasiveness. Taken together, these results indicate that PBMC‐derived macrophages and BM‐MSCs are recruited to a tumour site and activated into TAMs and CAFs, respectively, followed by the formation of favourable environments for neuroblastoma progression. © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2016-09-19 2016-10 /pmc/articles/PMC5095779/ /pubmed/27425378 http://dx.doi.org/10.1002/path.4769 Text en © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Papers
Hashimoto, Okito
Yoshida, Makiko
Koma, Yu‐ichiro
Yanai, Tomoko
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Nishimura, Noriyuki
Yokozaki, Hiroshi
Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title_full Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title_fullStr Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title_full_unstemmed Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title_short Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
title_sort collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095779/
https://www.ncbi.nlm.nih.gov/pubmed/27425378
http://dx.doi.org/10.1002/path.4769
work_keys_str_mv AT hashimotookito collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT yoshidamakiko collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT komayuichiro collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT yanaitomoko collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT hasegawadaiichiro collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT kosakayoshiyuki collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT nishimuranoriyuki collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment
AT yokozakihiroshi collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment